Deutsche Bank analyst George Hill raised the firm’s price target on Hims & Hers to $48 from $43 and keeps a Hold rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Hims & Hers Reports Strong Growth Amid Challenges
- ‘Time to Exit,’ as Bank of America Loses Faith in Hims & Hers Health Stock (HIMS)
- Mixed options sentiment in Hims and Hers Health with shares down 8.75%
- Hold Rating for Hims & Hers Health Amid Mixed Results and Growth Investments
- Hims & Hers Health: Hold Rating Amid Mixed Financial Performance and Strategic Transition